טוען...
Decline in opioid prescribing after federal rescheduling of hydrocodone products
PURPOSE: To examine differences in opioid prescribing by patient characteristics and variation in hydrocodone combination product (HCP) prescribing attributed to states, before and after the 2014 Drug Enforcement Administration’s reclassification of HCP from schedule III to the more restrictive sche...
שמור ב:
| הוצא לאור ב: | Pharmacoepidemiol Drug Saf |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5934339/ https://ncbi.nlm.nih.gov/pubmed/29271049 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pds.4376 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|